Otonomy to Report Fourth Quarter and Full Year 2015 Financial Results and Provide Corporate Update

Back to Jobs

Webcast and Conference Call to be Held at 4:30 p.m. ET on March 7, 2016 SAN DIEGO , Feb. 26, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today

Apply Now